The same concept may also be applicable to the prevention and treatment of disease caused by other respiratory pathogens, including the use of HDPs, such as lactoferrin, which was previously shown to be effective against respiratory syncytial virus infection [112]. The gene discussed is LTF; the disease is respiratory syncytial virus infectious disease.